Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturers:
|
Avonex Interferon beta-1a 60mcg/mL Solution for injection Biogen NZ Biopharma Limited Vetter Pharma-Fertigung GmbH & Co KG, Langenargen, Germany Cilag AG, Schaffhausen, Switzerland
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturers:
|
Avonex Pen Interferon beta-1a 60mcg/mL Solution for injection Biogen NZ Biopharma Limited Biogen Idec Denmark Manufacturing ApS, Hillerod, Denmark Vetter Pharma-Fertigung GmbH & Co KG, Langenargen, Germany Cilag AG, Schaffhausen, Switzerland Packaging Coordinators LLC, Pennsylvania, United States of America
|
Dated this 21st day of July 2016.
CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).